Polymyalgia Rheumatica: assessment and management in Brisbane

Written by , Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).

Polymyalgia rheumatica is an inflammatory condition that causes aching and marked morning stiffness around the shoulders and hips in people over 50. It is treated with prednisolone, and it is linked with giant cell arteritis, an inflammation of the arteries of the head that can threaten sight.

Polymyalgia rheumatica is diagnosed from the pattern of symptoms, raised inflammatory markers on blood tests, and the exclusion of conditions that can look similar, such as rheumatoid arthritis, rotator cuff disease, thyroid disease and other inflammatory or infective causes. There is no single confirming test. Assessment focuses on that pattern, on screening for giant cell arteritis at every visit, and on checking whether the shoulder and hip pain is better explained by something mechanical.

Treatment is led by medicine. Prednisolone is the foundation, usually started at a moderate dose and reduced over many months, with attention to bone protection, blood pressure and blood glucose while it is taken. Relapse during the taper is common, and rheumatology input is appropriate if symptoms keep returning or steroid side effects accumulate. Shared care between the GP and a rheumatologist is the norm, and this clinic supports that plan.

Rehabilitation has a clear place in keeping strength, walking speed and independence, particularly because the condition and its treatment can both erode them. First-line care is usually the medical plan plus an exercise programme matched to how stiff and weak the person is. None of the injection or device treatments sometimes used for tendon and joint problems has been shown to treat polymyalgia rheumatica itself, and they are not part of managing it. This page is for general education and does not replace an individual assessment.

Common symptoms

  • Aching and stiffness across both shoulders, often spreading to the upper arms, neck, hips and thighs
  • Morning stiffness lasting longer than 45 minutes that eases with movement
  • Difficulty raising the arms, dressing, or getting out of bed or a chair
  • Fatigue, low mood, a low-grade fever or weight loss alongside the stiffness
Every treatment reviewed for this diagnosis

Evidence for twelve treatment options in polymyalgia rheumatica

This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.

Foundation: diagnosis, education and rehabilitation

The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.

Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Adjunct to medical treatment

What it involves

Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.

What the evidence shows

Treatment is medical: glucocorticoid with a planned taper, reviewed against the European and American recommendations (Dejaco, Ann Rheum Dis 2024 treat-to-target). Exercise evidence is thin. One randomised crossover trial of home exercise was found, and it compared two protein supplements, not exercise against none (Bjorkman, J Nutr Health Aging 2011). An Australian cohort of 36 people showed greater disability, slower gait and more pre-frailty than matched controls up to 18 months after starting treatment, and the authors recommended routine functional assessment and muscle conditioning (Leung, Rheumatology 2025). An Australian survey of 149 people found many wanted specific exercise guidance (Osmotherly, Musculoskelet Care 2026).

Pairing reviewed 2026-10-11.

Where it fits

A reasonable adjunct once the diagnosis is made and treatment is under way, aimed at strength, walking and chair-rise ability, with the thin evidence stated. It sits alongside medical treatment and bone protection, never instead of it.

Muscle and symptom-modifying options

Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.

Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant

What it involves

The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.

What the evidence shows

A PubMed search pairing polymyalgia rheumatica with dry needling, wet needling or acupuncture found no randomised or controlled treatment trial.

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about wet needling and trigger point injection
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Only if relevant

What it involves

The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.

What the evidence shows

No trial located of image-guided injection as treatment for polymyalgia rheumatica itself; the established treatment is systemic prednisolone with a planned taper (Dejaco, Ann Rheum Dis 2024; Lancet 2023 review).

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about ultrasound-guided injections
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Only if relevant

What it involves

A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.

What the evidence shows

A PubMed search pairing polymyalgia rheumatica with vibration or percussive devices found no randomised or controlled treatment trial.

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about V-ACTOR vibration therapy

Energy-based treatment options

Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.

Radial or focused shockwave? Read the overview
Radial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Plausible: no studies

What it involves

A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.

What the evidence shows

A PubMed search pairing polymyalgia rheumatica with radial shockwave found no randomised or controlled treatment trial.

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about radial shockwave
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Plausible: no studies

What it involves

A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.

What the evidence shows

A PubMed search pairing polymyalgia rheumatica with focused shockwave found no randomised or controlled treatment trial.

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about focused shockwave (ESWT)
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies

What it involves

You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.

What the evidence shows

A PubMed search pairing polymyalgia rheumatica with electromagnetic transduction or pulsed electromagnetic therapy found no randomised or controlled treatment trial.

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about EMTT

Biologic and joint injection options

Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.

Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Plausible: no studies

What it involves

Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.

What the evidence shows

A PubMed search pairing polymyalgia rheumatica with platelet-rich plasma found no randomised or controlled treatment trial.

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about platelet-rich plasma (PRP)
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Plausible: no studies

What it involves

Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.

What the evidence shows

A PubMed search pairing polymyalgia rheumatica with prolotherapy or dextrose injection found no randomised or controlled treatment trial.

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about prolotherapy
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not offered for this

What it involves

One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.

What the evidence shows

Hyaluronic acid is for intra-articular problems. Polymyalgia rheumatica is a systemic inflammatory condition, and no trial of hyaluronic acid in it was found.

Pairing reviewed 2026-10-11.

Where it fits

Not offered. Treatment is systemic and medical.

Read more about viscosupplementation

Nerve-targeted options

Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.

Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Only if relevant

What it involves

Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.

What the evidence shows

A PubMed search pairing polymyalgia rheumatica with perineural injection or nerve block found no randomised or controlled treatment trial.

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about Lyftogt perineural therapy
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant

What it involves

Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.

What the evidence shows

A PubMed search pairing polymyalgia rheumatica with hydrodissection found no randomised or controlled treatment trial.

Pairing reviewed 2026-10-11.

Where it fits

Not part of managing polymyalgia rheumatica, which is an inflammatory condition treated with prednisolone under medical supervision. Only considered if a separate, localised problem is found on examination.

Read more about ultrasound-guided nerve hydrodissection

This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.

Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.

A note on cortisone

Corticosteroid injection is reviewed separately for each diagnosis.

Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.

So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.

When it might still be considered

  • Pain severe enough to block rehabilitation
  • A clear inflammatory or bursal target on imaging
  • A specific short-term goal: a trip, a procedure, a return to work
  • Diagnostic use, where the response shows where the pain is coming from

When a cortisone injection is worth doing, and when it is not

Other general conditions

Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.

Frequently asked questions

Which symptoms mean I should be seen the same day?
New headache, scalp tenderness, jaw pain when chewing, or any blurring, double vision or loss of vision, especially in someone over 50 with shoulder or hip stiffness. These can be signs of giant cell arteritis, which can cause permanent loss of sight. These need same-day assessment from a GP or an emergency department, without waiting for a routine appointment.
Do I need to stay on prednisolone for a long time?
Usually for a year or more. Treatment starts at a moderate dose that works quickly in most people, then the dose is reduced slowly. Symptoms return as the dose falls in a large share of people, with studies reporting anywhere from about 40 to 76 per cent, so reviews are planned and some people are referred to a rheumatologist for steroid-sparing medicines. Prednisolone should not be stopped or reduced without medical advice.
Is there anything beyond medication that helps?
Staying active matters. Studies of Australians with this condition found reduced walking speed and strength compared with people of the same age, and many report wanting clearer exercise advice. Trials of exercise in this specific condition are limited, so strength and mobility work sits alongside medical treatment and bone protection, not in place of them.

Ready for a clearer plan for your back or musculoskeletal pain?

Book an assessment with Dr Joshua Hatch.

Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.

You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.

Book an appointment
Book an appointment with Back Pain Doctor